Claire Mazumdar, Bicara Therapeutics CEO
Oncology biotech Bicara unveils IPO pitch same day as Zenas
For a while, there were none. Suddenly, there were two.
Bicara Therapeutics filed Thursday afternoon for an initial public offering, just …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
